![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, July 12, 2022 11:42:41 PM
I know you have reservations with the risks you've identified; Lawsuit, Private Placements, Moonlighting, public exposure.
Those risks are or aren't within your tolerances nothing wrong with buy hold sell trade or short it.
Lawsuit perspective from me is there is 0 worst case scenario that stops company progress.
Private Placements are much better than dilution, we are prerevenue and it's the name of the game. You know who is footing the bill.
When Dr. Burba went full-time IBAT it appears it was progress related and he left Molycorp around that time (Mar 2021). He has also been able to work on and get approved many patents, some outside of IBAT (see terralithium with Dr. Harrison). The equipment is capable of all brine types. Some have stated he's testing multiple brines for compatibility while I speculate he's testing to gather his data to extract from each specific brine with future units.
Dr. Burba stated himself he is about performance and execution, the technology will speak for itself as it relates to PR and exposure.
I am position A.
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM